AC Immune SA

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
5.59+0.0100+0.18%Vol 2 9451Y Perf -34.00%
Aug 23rd, 2019 09:53
BID5.55 ASK5.58
Open5.57 Previous Close5.58
Pre-Market- After-Trading-
 - -%  - -%
Target Price
12.00 
Analyst Rating
Strong Buy 1.50
Potencial %
114.67 
Finscreener Ranking
★★★★★     64.84
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★★★     69.92
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★★     74.35
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)378 
Earnings Rating
Sell
Price Range Ratio 52wk %
25.30 
Earnings Date
14th Aug 2019

Today's Price Range

5.535.64

52wk Range

3.2512.50

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Sell
Performance
1 Week
3.72%
1 Month
2.95%
3 Months
15.05%
6 Months
28.28%
1 Year
-34.00%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
ACIU5.590.01000.18
AAPL211.64-0.8200-0.39
GOOG1 191.151.62000.14
MSFT135.93-1.8500-1.34
XOM69.41-0.1600-0.23
WFC45.35-0.2700-0.59
JNJ128.99-2.2800-1.74
FB182.610.57000.31
GE8.06-0.1300-1.59
JPM108.38-0.3400-0.31
Earnings HistoryEstimateReportedSurprise %
Q02 2019-0.24-0.234.17
Q01 20191.340.84-37.31
Q04 20180.55-0.22-140.00
Q03 2018-0.27-0.1929.63
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Earnings Per EndEstimateRevision %Trend
9/2019 QR-0.24-4.35Negative
12/2019 QR-0.250.00-
12/2019 FY0.170.00-
12/2020 FY-0.600.00-
Next Report Date-
Estimated EPS Next Report-0.23
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume2 945
Shares Outstanding (in ths.)67 562
Trades Count558
Dollar Volume528 317
Avg. Volume329 494
Avg. Weekly Volume62 529
Avg. Monthly Volume104 667
Avg. Quarterly Volume95 769
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.50
Strong Buy
1.50

AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.

CEO: Andrea Pfeifer

Teplephone: +41 216939121

Address: EPFL Innovation Park, Lausanne 1015, , CHE

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

36%64%

Bearish Bullish

60%40%

Bearish Bullish

69%31%

News